| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |